For example, the incorporation of canine complement regulatory proteins into the Newcastle disease viral envelope by growing the virus in host-specific cells that are transfected with or naturally express the CD46 or CD55 complement regulatory proteins may confer resistance of the virus to neutralization by complement, or genetically engineering the virus to express immunostimulatory cytokines [30]. The gene discussed is CD46; the disease is Newcastle disease.